CompletedNot Applicable

Family Psychoeducation for Adults With Psychotic Disorders in Tanzania

Tanzania66 participantsStarted 2019-08-06

Plain-language summary

The goal of this study is to pilot test a culturally tailored Family Psychoeducation model (KUPAA) for adults with psychotic disorders and their relatives that is appropriate for cultural settings inclusive of both traditional and biomedical ideas about mental illness and that incorporates relatives as co-facilitators of the intervention.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patient Inclusion Criteria: * Attending outpatient psychiatric services at Muhimbili National Hospital (MNH) or Mbeya Zonal Referral Hospital (MZRH). * ICD-10 Diagnosis of a non-organic psychotic disorder: * F20 Schizophrenia * F21 Schizotypal disorder * F22 Delusional disorders * F25 Schizoaffective disorders * Age 18-50 at the time of informed consent * Hospitalization or relapse (confirmed by attending psychiatrist or medical officer) within the past 12 months. Patient Exclusion Criteria: * F23 Brief psychotic disorder * F28 Other psychotic disorder not due to a substance or known physiological condition * F29 Unspecified psychosis not due to a substance or known physiological condition * Epileptic psychoses * Bipolar disorder and mania * Co-morbid developmental disorder, dementia, or other severe cognitive deficit that renders the individual unable to provided informed consent. Caregiver Inclusion Criteria: * Age 18 or older at time of consenting process * Patient agrees that this person can be their paired partner for KUPAA if the pair is randomized to the intervention group

What they're measuring

Proportion of Patient Participants Who Experience Illness Relapse

Timeframe: Relapse is measured from immediate post-intervention to endline (~6-7 months post-intervention)

Change From Baseline to Endline in Disability, as Measured by the World Health Organization Disability Assessment Schedule Version 2.0 (WHODAS 2.0)

Timeframe: Baseline (pre-intervention) and Endline (~6-7 months post-intervention)

Change From Baseline to Endline in Quality of Life, as Measured by the World Health Organization Quality of Life- Abbreviated Version (WHOQOL-BREF)

Timeframe: Baseline (pre-intervention) and Endline (~6-7 months post-intervention)

Trial details

NCT IDNCT04013932

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-27

Results submitted2021-11-17

View on ClinicalTrials.gov More Schizophrenia Spectrum and Other Psychotic Disorders trials

Plain-language summary

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Proportion of Patient Participants Who Experience Illness Relapse

Timeframe: Relapse is measured from immediate post-intervention to endline (~6-7 months post-intervention)

Change From Baseline to Endline in Disability, as Measured by the World Health Organization Disability Assessment Schedule Version 2.0 (WHODAS 2.0)

Timeframe: Baseline (pre-intervention) and Endline (~6-7 months post-intervention)

Change From Baseline to Endline in Quality of Life, as Measured by the World Health Organization Quality of Life- Abbreviated Version (WHOQOL-BREF)

Timeframe: Baseline (pre-intervention) and Endline (~6-7 months post-intervention)